Literature DB >> 17849358

Society of Toxicologic Pathology position paper: organ weight recommendations for toxicology studies.

Rani S Sellers1, Daniel Morton, Bindhu Michael, Nigel Roome, Julie K Johnson, Barry L Yano, Rick Perry, Ken Schafer.   

Abstract

The evaluation of organ weights in toxicology studies is an integral component in the assessment of pharmaceuticals, chemicals, and medical devices. The Society of Toxicologic Pathology (STP) has created recommendations for weighing organs in GLP general toxicology studies lasting from 7 days to 1 year. The STP recommends that liver, heart, kidneys, brain, testes, and adrenal glands be weighed in all multidose general toxicology studies. Thyroid gland and pituitary gland weights are recommended for all species except mice. Spleen and thymus should be weighed in rodent studies and may be weighed in non-rodent studies. Weighing of reproductive organs is most valuable in sexually mature animals. Variability in age, sexual maturity, and stage of cycle in non-rodents and reproductive senescence in female rodents may complicate or limit interpretation of reproductive organ weights. The STP recommends that testes of all species be weighed in multidose general toxicology studies. Epididymides and prostate should be weighed in rat studies and may be weighed on a case-by-case basis in non-rodent and mouse studies. Weighing of other organs including female reproductive organs should be considered on a case-by-case basis. Organ weights are not recommended for any carcinogenicity studies including the alternative mouse bioassays. Regardless of the study type or organs evaluated, organ weight changes must be evaluated within the context of the compound class, mechanism of action, and the entire data set for that study.

Entities:  

Mesh:

Year:  2007        PMID: 17849358     DOI: 10.1080/01926230701595300

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  48 in total

1.  Acute, subacute, and subchronic exposure to 2A-DNT (2-amino-4,6-dinitrotoluene) in the northern bobwhite (Colinus virginianus).

Authors:  Michael J Quinn; Craig A McFarland; Emily M Lafiandra; Matthew A Bazar; Mark S Johnson
Journal:  Ecotoxicology       Date:  2010-03-09       Impact factor: 2.823

2.  Normal organ weights, serum chemistry, hematology, and cecal and nasopharyngeal bacterial cultures in the gray short-tailed opossum (Monodelphis domestica).

Authors:  Kristin D Evans; Terry A Hewett; Cindy J Clayton; Leah A Krubitzer; Stephen M Griffey
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-07       Impact factor: 1.232

3.  DNA damage in kidney and parenchymal and non-parenchymal liver cells of adult Wistar rats after subchronic oral treatment with tembotrione.

Authors:  Vilena Kašuba; Vedran Micek; Alica Pizent; Blanka Tariba Lovaković; Davor Želježić; Mirta Milić; Nevenka Kopjar
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-22       Impact factor: 4.223

4.  Scientific and Regulatory Policy Committee (SRPC) Points to Consider: Histopathology Evaluation of the Pubertal Development and Thyroid Function Assay (OPPTS 890.1450, OPPTS 890.1500) in Rats to Screen for Endocrine Disruptors.

Authors:  Kevin A Keane; George A Parker; Karen S Regan; Catherine Picut; Darlene Dixon; Dianne Creasy; Dipak Giri; Renee R Hukkanen
Journal:  Toxicol Pathol       Date:  2015-05-06       Impact factor: 1.902

5.  Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development.

Authors:  Wendy G Halpern; Mehrdad Ameri; Christopher J Bowman; Michael R Elwell; Michael L Mirsky; Julian Oliver; Karen S Regan; Amera K Remick; Vicki L Sutherland; Kary E Thompson; Claudine Tremblay; Midori Yoshida; Lindsay Tomlinson
Journal:  Toxicol Pathol       Date:  2016-05-27       Impact factor: 1.902

6.  Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer.

Authors:  Lauren E Himmel; Maryam B Lustberg; A Courtney DeVries; Ming Poi; Ching-Shih Chen; Samuel K Kulp
Journal:  Exp Toxicol Pathol       Date:  2016-08-21

7.  Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats.

Authors:  Jia-Long Fang; Michelle M Vanlandingham; Frederick A Beland; Robert P Felton; Mackean P Maisha; Greg R Olson; Ralph E Patton; Amy S Rosenberg; Gonçalo Gamboa da Costa
Journal:  Toxicol Lett       Date:  2022-01-29       Impact factor: 4.372

8.  Luteolin prevents irinotecan-induced intestinal mucositis in mice through antioxidant and anti-inflammatory properties.

Authors:  Thaise Boeing; Priscila de Souza; Silvia Speca; Lincon Bordignon Somensi; Luisa Nathália Bolda Mariano; Benhur Judah Cury; Mariana Ferreira Dos Anjos; Nara Lins Meira Quintão; Laurent Dubuqoy; Pierre Desreumax; Luisa Mota da Silva; Sérgio Faloni de Andrade
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

9.  Effects of intravenous and oral di(2-ethylhexyl) phthalate (DEHP) and 20% Intralipid vehicle on neonatal rat testis, lung, liver, and kidney.

Authors:  Luísa Camacho; John R Latendresse; Levan Muskhelishvili; Charles D Law; K Barry Delclos
Journal:  Food Chem Toxicol       Date:  2020-06-13       Impact factor: 6.023

10.  Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments.

Authors:  Sajid Ali; Muhammad Umair Amin; Imran Tariq; Muhammad Farhan Sohail; Muhammad Yasir Ali; Eduard Preis; Ghazala Ambreen; Shashank Reddy Pinnapireddy; Jarmila Jedelská; Jens Schäfer; Udo Bakowsky
Journal:  Int J Nanomedicine       Date:  2021-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.